Corporate Profile Protagenic Therapeutics Inc. is a biotechnology company focusing on the discovery and development of novel, naturally occurring human brain hormones for the treatment of anxiety- and depression-based mood disorders. The mission of the Protagenic Therapeutics Inc is to provide innovative, safe and effective treatments for anxiety and depression by using natural neuropeptide hormones to restore normal emotionality. The Company has created a proprietary portfolio of novel neuropeptides based on the TCAP family of natural peptides, which are in various stages of development and preclinical evaluation for the treatment of neurological disorders. Intellectual Property Opportunity As part of Protagenic Therapeutics’ expansion of its innovative portfolio of products, the Company is interested in acquiring and obtaining exclusive intellectual property rights for peptide-based therapeutics for the treatment of neurological and mood disorders as well as natural products for the maintenance of general health and well being. For further information, please contact us at infopti@protagenic.com.
|
